Noninvasive measurement of phenylalanine by iontophoretic extraction in patients with phenylketonuria
- PMID: 17912613
- DOI: 10.1007/s10545-007-0675-y
Noninvasive measurement of phenylalanine by iontophoretic extraction in patients with phenylketonuria
Abstract
Phenylketonuria is an autosomal recessive disorder characterized by elevated concentrations of phenylalanine. Elevated phenylalanine concentrations can impair intellectual functions and the disease is treated with a lifelong diet and frequent monitoring of plasma phenylalanine concentrations. Previous in vitro studies have demonstrated the feasibility of iontophoretically enhanced transdermal transport of phenylalanine. Here we evaluate the feasibility of transdermal iontophoretic extraction of phenylalanine in vivo. Phenylalanine was iontophoretically extracted from the skin of healthy volunteers and of patients with phenylketonuria for up to 6 h and concentrations were compared with those measured in plasma. The amount of phenylalanine iontophoretically extracted from the skin declined over time, suggesting contribution of phenylalanine from the skin in the initial extraction. Phenylalanine iontophoretically extracted from skin correlated with plasma phenylalanine levels at plasma levels above 300 micromol/L. This correlation supports the feasibility of iontophoretic phenylalanine extraction for monitoring phenylketonuria.
Similar articles
-
Maternal phenylketonuria.Wiad Lek. 2009;62(1):11-7. Wiad Lek. 2009. PMID: 19817251
-
L-Phenylalanine concentration in blood of phenylketonuria patients: a modified enzyme colorimetric assay compared with amino acid analysis, tandem mass spectrometry, and HPLC methods.Clin Chem Lab Med. 2010 Sep;48(9):1271-9. doi: 10.1515/CCLM.2010.271. Clin Chem Lab Med. 2010. PMID: 20604724
-
Comparison of two different methods for measurement of phenylalanine in dried blood spots.Clin Chem Lab Med. 2000 Aug;38(8):773-6. doi: 10.1515/CCLM.2000.110. Clin Chem Lab Med. 2000. PMID: 11071072
-
Performance of laboratory tests used to measure blood phenylalanine for the monitoring of patients with phenylketonuria.J Inherit Metab Dis. 2020 Mar;43(2):179-188. doi: 10.1002/jimd.12163. Epub 2019 Oct 2. J Inherit Metab Dis. 2020. PMID: 31433494 Free PMC article. Review.
-
Brain dysfunction in phenylketonuria: is phenylalanine toxicity the only possible cause?J Inherit Metab Dis. 2009 Feb;32(1):46-51. doi: 10.1007/s10545-008-0946-2. Epub 2009 Jan 13. J Inherit Metab Dis. 2009. PMID: 19191004 Review.
Cited by
-
Reverse iontophoresis of amino acids: identification and separation of stratum corneum and subdermal sources in vitro.Pharm Res. 2009 Dec;26(12):2630-8. doi: 10.1007/s11095-009-9978-z. Epub 2009 Oct 6. Pharm Res. 2009. PMID: 19806434
-
Interindividual- and blood-correlated sweat phenylalanine multimodal analytical biochips for tracking exercise metabolism.Nat Commun. 2024 Jan 20;15(1):624. doi: 10.1038/s41467-024-44751-z. Nat Commun. 2024. PMID: 38245507 Free PMC article.
-
New Strategies for the Treatment of Phenylketonuria (PKU).Metabolites. 2014 Nov 4;4(4):1007-17. doi: 10.3390/metabo4041007. Metabolites. 2014. PMID: 25375236 Free PMC article. Review.
-
Epidermal Wearable Biosensors for the Continuous Monitoring of Biomarkers of Chronic Disease in Interstitial Fluid.Micromachines (Basel). 2023 Jul 20;14(7):1452. doi: 10.3390/mi14071452. Micromachines (Basel). 2023. PMID: 37512763 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical